Get access to well characterized pre-clinical chemical and biological molecules to unlock their full potential for the benefit of patients with high medical need – either for free or as part of a collaboration.

Solve challenging biological questions with innovative ideas and collaborate with us to access funding and to foster innovation in area of high unmet medical need.

This platform has been developed by Boehringer Ingelheim scientists recognized for their drug discovery capabilities and technical skills. Their focus is on the quality of their compounds and on their high level of openness to new ideas.

Our philosophy is one of respectful collaboration in an open and supportive manner using molecules that catalyze a stimulating exchange of ideas and science and come up with new potential treatment concepts for patients.

OUR AIM

With opnMe we have two objectives: The first one is to openly share well-characterized pre-clinical tool compounds with scientists from around the world who seek straightforward access to molecules of highest quality. These molecules can be either ordered free of charge or accessed as part of a collaboration with our scientists. The second objective is to find solutions to key biologic questions through research challenges that are open to all scientific experts worldwide. Through these initiatives, we believe that together we can accelerate research initiatives and foster innovation in areas of high unmet medical need.

Collaboration

We hope to be able to interact with scientists from around the world who share the same passion for scientific excellence as we do. We think that scientists who are focused on problem-solving, inspired by new discoveries and technologies and eager to try out something new will find the right molecules or exciting scientific challenges and questions on opnMe.com.

QUALITY

All molecules on this platform have gone through a rigorous internal review process where we looked at quality and disease relevance. We have focused on molecule quality which is characterized through the great level of detail that we provide upfront to allow an independent assessment of their strengths. We belief our molecules are unique and target molecular pathways of relevance to human disease.

TRANSPARENCY

The transparency is two-fold: Initially focusing on the profiles of our molecules where we provide a comprehensive pre-clinical data package for each of the compounds. But it’s also about the transparency with regards to the rights and obligations of the scientists who approach the portal to submit their exclusive ideas, in particular with regards to intellectual property.

BENEFIT

We aim to create a new way to help scientists to validate their scientific hypotheses and to independently publish their data to advance scientific knowledge. It should add an opportunity for scientists to advance science and to interact with Boehringer Ingelheim scientists if they wish. Ultimately, we hope to increase their network and experience.